Atlas market file · Equity · United States
Innovative Eyewear IncLUCY
- Last close
- 0.7135
- Change
- -3.84%
- 96-bar range
- 0.65 – 1.72
- As of
- 5 Aug 2026
Innovative Eyewear Inc is an ophthalmic goods issuer listed as LUCY on NASDAQ. Use this page to check the price chart, company context, source-backed updates, risks and evidence before opening the full Atlas research file.
- Identity
- Nasdaq Trader
- Chart rail
- TradingView
- File state
- Public profile
LUCY
Equity · evidence first
Static Daily candlestick snapshot from the approved cache, drawn on a labelled price axis: green bodies closed up, red closed down, wicks span each bar's high-to-low range. The live TradingView link stays available; the public profile never embeds a widget that can render the wrong symbol.
▮ up candle ▮ down candle
Weekly outlook: the last 104 weekly closes (-80.61% over the window).
Source rail: Yahoo Finance chart API (LUCY). This dated snapshot is the crawlable Atlas reference.
Live market viewTradingView · provider feed Open view ->
Open the attributed TradingView market view for LUCY. The dated Atlas snapshot above remains the crawlable reference; exchange data in this panel may be live or delayed as labelled by TradingView.
LUCY public profile
Ophthalmic goods issuer. Innovative Eyewear Inc is connected to current market context, cited company sources and its retained research file.
Innovative Eyewear Inc trades as LUCY on NASDAQ. Innovative Eyewear Inc (LUCY) has a latest verified close of 0.7135, down 3.84%, dated 5 Aug 2026.
Open the chart, inspect attributed company evidence and continue into the fuller research file without losing this market context. Atlas files LUCY under USA Stocks for browsing.
What changed for Innovative Eyewear Inc today
Innovative Eyewear Inc. (LUCY) reported a net loss of $2.3M on $773,561 revenue in Q1 2026, per its 10-Q filing, despite touting ‘technological advancements’ in its Lucyd Lyte smart eyewear line. The company’s cash reserves stood at $4.4M, but operating activities consumed $2.5M, raising questions about its ability to sustain operations without further dilution.
LUCY’s core product, the Lucyd Lyte® smart glasses, has expanded since 2021 with partnerships like the Eddie Bauer® rimless design launched in April 2024. However, inventory levels remain elevated at $1.4M, even as the company reported a $264,924 decrease in inventory value-a mixed signal in a niche market where tech obsolescence looms.
The July 23 S-1 filing reveals plans for a public offering, with an exercise price of $8.228 per share, though the firm’s diluted EPS remains negative at -$0.37. Recent 8-K and 144 filings show executive share disposals and insider transactions, underscoring governance risks as the board pursues growth amid financial strain.
Chart-wise, LUCY’s liquidity remains untested in major exchanges, with thin trading volumes inferred from its micro-cap profile. No technical levels are validated by the evidence, though the $8.228 exercise price may act as a psychological reference if the offering proceeds.
The company’s survival hinges on converting its product pipeline into sustainable revenue. A successful offering could buy time, but without a turnaround in operating cash flow or inventory turnover, LUCY risks becoming a case study in style over substance.
Sources & evidence · 10 links
This is the public answer layer. The full Atlas report adds the complete Market Wit archive, risk rail, catalyst map, final editor synthesis, PDF/CSV export, email delivery and saved history.
LUCY technical readout
Directional bias up. Wilder ADX and ATR computed from Atlas approved daily OHLC through 2026-07-28. Indicators are descriptive statistics, not investment advice.
Open an Atlas research path on LUCY
FreedomCore Atlas can expand this public profile into source-led research files with company snapshots, valuation context, filings and segment detail, source packs, and equity briefs. Each path keeps the underlying public sources visible.
Open Atlas workstation ->Keep LUCY research in your Atlas archive
Free Atlas includes the public profile and one owned welcome research artifact after account setup. Atlas Pro adds up to 25 custom research runs a day, a 500-symbol watchlist, saved report versions, and eligible PDF, CSV, and email artifacts. Evidence holds still apply and never become an unverified download. £12/month founding price, locked for life. Research only; not investment advice.
Checking Atlas access...
LUCY FAQ
What is Innovative Eyewear Inc (LUCY)?Innovative Eyewear Inc (LUCY) has a latest verified close of 0.7135, down 3.84%, dated 5 Aug 2026. Use this page to check the price chart, company context,...
Innovative Eyewear Inc (LUCY) has a latest verified close of 0.7135, down 3.84%, dated 5 Aug 2026. Use this page to check the price chart, company context, source-backed updates, risks and evidence before opening the full Atlas research file.
What does Atlas show for LUCY?Innovative Eyewear Inc (LUCY) has a latest verified close of 0.7135, down 3.84%, dated 5 Aug 2026. It brings the latest available chart, company context, cited sources,...
Innovative Eyewear Inc (LUCY) has a latest verified close of 0.7135, down 3.84%, dated 5 Aug 2026. It brings the latest available chart, company context, cited sources, risks and the route into the full Atlas research file together. Atlas files LUCY under USA Stocks for browsing.
How often is the LUCY page updated?The LUCY public file is refreshed when a newer verified market bar, company filing, official release or material source update is available. The visible date shows the...
The LUCY public file is refreshed when a newer verified market bar, company filing, official release or material source update is available. The visible date shows the freshness of the current market snapshot.
Which sources does Atlas use for LUCY?The LUCY file starts with SEC EDGAR filings, Nasdaq Trader and TradingView NASDAQ:LUCY. SEC EDGAR provides the filing anchor for this issuer. The page separates...
The LUCY file starts with SEC EDGAR filings, Nasdaq Trader and TradingView NASDAQ:LUCY. SEC EDGAR provides the filing anchor for this issuer. The page separates verified market context from company evidence and shows open evidence gaps instead of filling them with assumptions.
Can Atlas run a full research brief on LUCY?Yes. The workstation can open LUCY, expand the public source set into a fuller browser report, and add email, PDF or CSV export where the account tier allows it.
Yes. The workstation can open LUCY, expand the public source set into a fuller browser report, and add email, PDF or CSV export where the account tier allows it.
Is this LUCY page investment advice?No. The LUCY page is a research and source-navigation page. It does not provide personalised financial advice, brokerage execution, a trading instruction, or a promise...
No. The LUCY page is a research and source-navigation page. It does not provide personalised financial advice, brokerage execution, a trading instruction, or a promise of returns.
Methodology
This profile is generated daily from public sources including SEC EDGAR (US-listed companies), NASDAQ Trader files, exchange listings, public macro/central-bank releases, CoinGecko crypto market files where relevant, and the TradingView global symbol catalog. Multi-model AI may assist drafting and review where configured, but sources remain the evidence rail; the chart is an Atlas static OHLC rail with a live TradingView link when verified bars are available; otherwise the page keeps the verified TradingView route as an explicit fallback.
Research only. Not investment advice. No brokerage execution. No guaranteed returns are promised or implied. FreedomCore does not provide personalised investment advice. Always consult a regulated financial advisor before making investment decisions.
Profile last updated: 2026-07-29. Browse FreedomCore Atlas research notes →